Method, compositions, and compounds for allosteric modulation of

Details Method, compositions, and compounds for allosteric modulation of Method, compositions, and compounds for allosteric modulation of

1997-07-02

1999-08-17

Dees, Jose G.

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

540106, 540107, 540108, 552600, C07J 4100, C07J 4300, C07J 500

Patent

active

059395451

ABSTRACT:
Methods, compositions, and compounds for modulating the GABA.sub.A receptor-chloride ionophore complex to alleviate stress, anxiety, seizures, mood disorders, PMS and PND and to induce anesthesia.

REFERENCES:
patent: 3274179 (1966-09-01), Christensen et al.
patent: 3983111 (1976-09-01), Phillipps et al.
patent: 5120723 (1992-06-01), Gee et al.
patent: 5208227 (1993-05-01), Gee et al.
patent: 5232917 (1993-08-01), Bolger et al.
patent: 5319115 (1994-06-01), Tahir et al.
patent: 5359054 (1994-10-01), Ottow et al.
patent: 5359055 (1994-10-01), Tsuji et al.
Jacobsen et al., "Novel 21-aminosteroids that inhibit iron-dependent lipid peroxidation and protect against central nervous system trauma", J. Med. Chem. 33(4), 1145-1151, 1990.
Phillipps, G.H. "Structure-Activity Relationships in Steroidal Anaesthetics," J. Steroid Biochem. 6:607-613 (1975).
Phillipps, G.H. et al., "Water-Soluble Steroidal Anaestheticss," J. Steroid Biochem. 11:79-86 (1979).
European Search Report for Application No. EP 95 91 3478 (Nov. 6, 1997).
Phillipps, G.H., "Structure-Activity Relationships in Steroidal Anaesthetics," J. Steroid Biochem. 6(5):32-47 (1975).
Supplementary European Search Report for European Application No. EP 95913478, mailed Mar. 20, 1998.
Aird, R.B. and Gordan, G.S., "Anticonvulsive Properties of Desoxycorticosterone," J. Amer. Med. Assoc. 145(10):715-719 (1951).
Arafat et al., "Sedative and hypnotic effects of oral administration of micronized and progesterone may be mediated through its metabolites," Am. J. Obstet. Gynecol. 159(5):1203-1209 (1988).
Backstrom et al., "Endocrinological Aspects of Cyclical Mood Changes During the Menstrual Cycle or the Premenstrual Syndrome," J. Psychosom. Obstet. Gynaecol. 2:8-20 (1983).
Backstrom et al., "Ovarian Steroid Hormones--Effects on mood, behaviour and brain excitability," Acta Obstet. Gynecol. Scand. Suppl. 130:19-24 (1985).
Belelli et al., "Anticonvulsant profile of the progesterone metabolite 5.alpha.-pregnan-3.alpha.-ol-20-one," Eur. J. Pharmacol. 166(2):325-329 (1989).
Bodor, N., "Novel Approaches in Prodrug Design," Drugs of the Future 6(3):165-182 (1981).
Callachan et al, "Modulation of the GABA.sub.A receptor by progesterone metabolites," Proc. R. Soc. Lond. B 231:359-369 (1987).
Conney et al., "Decreased Central Depressant Effect of Progesterone and other Steroids in Rats Pretreated with Drugs and Insecticides," J. Pharmacol. Exp. Ther. 154:310-318 (1966).
Dennerstein et al., "Progesterone and the premenstrual syndrome: a double blind crossover trial," British Med. J. 290:1617-1621 (1985).
Gee, K.W. and Yamamura, H.I., "Benzodiazepines and Barbiturates: Drugs for the Treatment of Anxiety, Insomnia, and Seizure Disorders," in: Drugs in Central Nervous System Disorders, D.C. Horwell, ed., pp. 123-147 (1985).
Gee et al., "GABA-Dependent Modulation of the Cl.sup.- Ionophore by Steroids in Rat Brain," Eur. J. Pharmacol. 136:419-423 (1987).
Gee et al., "Modulation of the Chloride Ionophore by Benzodiazepine Receptor Ligands: Influence of .gamma.-Aminobutyric Acid and Ligand Efficacy," Molec. Pharmacol. 30:218-225 (1986).
Gyermek, L., "Pregnanolone: A Highly Potent, Naturally Occurring Hypnotic-Anesthetic Agent," Proc. Soc. Exper. Biol. Med. 125:1058-1062 (1967).
Gyermek et al., "Structure-Activity Relationship of Some Steroidal Hypnotic Agents," J. Med. Chem. 11:117-125 (1968).
Harrison et al., "Structure-Activity Relationships for Steroid Interaction with the .gamma.-Aminobutyric Acid.sub.A Receptor Complex," J. Pharmacol. Exp. Ther. 241(1):346-353 (1987).
Horwell et al., "A Facile Method to Append Peptidal Side-Chains onto Steroidal Templates," Tetrahedron Lett. 50(14):4225-4234 (Mar. 1994).
Laidlaw, J., "Catamenial Epilepsy," The Lancet, pp. 1235-1237 (Dec. 15, 1956).
Lambert et al., "Actions of synthetic and endogenous steroids on the GABA.sub.A receptor," Trends in Pharm. Sci. 8:224-227 (1987).
Lawrence et al., "Benzodiazepine Anticonvulsant Action: .gamma.-Aminobutyric Acid-Dependent Modulation of the Chloride Ionophore," Biochem. Biophys. Res. Comm. 123(3):1130-1137 (1984).
Lloyd, K.G. and Morselli, P.L., "Psychopharmacology of GABAergic Drugs," in: Psychopharmacology: The Third Generation of Progress, H.Y. Meltzer (ed.), Raven Press, NY, pp. 183-195 (1987).
Maddocks et al., "A Double-blind placebo-controlled trial of progesterone vaginal suppositories in the treatment of premenstrual syndrome," Am. J. Obstet. Gynecol. 154:573-581 (1986).
Majewska et al., "Steroids and Brain Activity. Essential Dialogue Between Body and Mind," Biochem. Pharmacol.36(22):3781-3788 (1987).
Majewska et al., "Steroid Hormone Metabolites Are Barbiturate-Like Modulators of the GABA Receptor," Science 232:1004-1007 (1986).
Marker et al., "Isolation of epi-Pregnanol-3-one-20 from Human Pregnancy Urine," J. Amer. Chem. Soc. 59:616-618 (1937).
Mattson et al., "Medroxyprogesterone Therapy for Catamenial Epilepsy," Advances in Epileptology, vol. 15, Porter et al. (eds.), Washington, DC, Sep. 26-30, 1983, Raven Press, NY, pp. 279-282 (1984).
Mendelson et al., "Sleep induction by an adrenal steroid in the rat," Psychopharmacology 93:226-229 (1987).
Notari, R.E., "Theory and Practice of Prodrug Kinetics," Meth. Enzymol. 112:309-323 (1985).
Pfaff, D.W. and McEwen, B.S., "Actions of Estrogens and Progestins on Nerve Cells," Science 219:808-814 (1983).
Purdy et al., "Synthesis, Metabolism, and Pharmacological Activity of 3.alpha.-Hydroxy Steroids Which Potentiate GABA-Receptor-Mediated Chloride Ion Uptake in Rat Cerebral Cortical Synaptoneurosomes," J. Med. Chem. 33:1572-1581 (1990).
Raisinghani et al., "Uptake of Intravenously Administered Progesterone, Pregnanedione and Prenanolone by the Rat Brain," Acta Endocrinologica 57:395-404 (1968).
Rosciszewska et al., "Ovarian hormones, anticonvulsant drugs, and seizures during the menstrual cycle in women with epilepsy," J. Neurol. Neurosurg. Psych. 49:47-51 (1986). Affinity to Brain-Specific Sites Coupled to .gamma.-Aminobutyric Acid-A and Ion Recognition Sites," Molec. Pharmacol. 23:326-336 (1983).
Swinyard, E.A. and Woodhead, J.H., "Experimental Detection Quantification, and Evaluation of Anticonvulsants," in: Antiepileptic Drugs, Woodbury et al. (eds.), Raven Press, NY, pp. 111-126 (1982).
Wood et al., "In Vitro Characterization of Benzodiazepine Receptor Agonists, Antagonists, Inverse Agonists and Agonist/Antagonists," J. Pharmacol. Exp. Ther. 231(3):572-576 (1984).
Worms et al., ".gamma.-Aminobutyric Acid (GABA) Receptor Stimulation. I. Neuropharmacological Profiles of Progabide (SL 76002) and SL 75102, with Emphasis on their Anticonvulsant Spectra," J. Pharmacol. Exp. Ther. 220(3):660-671 (1982).

Affiliated with

Also associated with

Rating

Method, compositions, and compounds for allosteric modulation of does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method, compositions, and compounds for allosteric modulation of, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method, compositions, and compounds for allosteric modulation of will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-315884